Baxter BioPharma Solutions a pioneer in the delivery and production of sterile drugs expanded its sterile fill/finish manufacturing facilities located in Bloomington, Ind. Further, a high-speed automated syringe fills line with a fill rate of up to 600 units per minute, and a new high-speed automated visual inspection line were all part of the facility's planned infrastructure expansion.
BG (Becton, Dickinson and Company) introduced BD Effivax Glass Prefillable Syringe to establish a new benchmark for vaccine PFS performance. Further, it is expected to provide clients with additional support to handle the demanding requirements of today's vaccine manufacturing through design improvements targeted at fill/finish and container dependability.
Author Credits: Radhika Gupta, Shivam Bhutani